Fingerprint
Dive into the research topics of 'Gefitinib in patients with malignant mesothelioma: A phase II study by the cancer and leukemia group B'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Gefitinib in patients with malignant mesothelioma: A phase II study by the cancer and leukemia group B
Ramaswamy Govindan, Robert A. Kratzke, James E. Herndon, Gloria A. Niehans, Robin Vollmer, Dorothy Watson, Mark R. Green, Hedy L. Kindler
Research output: Contribution to journal › Article › peer-review
230
Scopus
citations